Storys aus Calgary, Alberta

Filtern
  • 17.01.2014 – 16:01

    Alberta Electric System Operator

    Five Companies Selected to Bid on Fort McMurray West 500 kV Transmission Project

    Calgary, Alberta (ots/PRNewswire) - The Alberta Electric System Operator (AESO) has announced the five companies who will compete for the opportunity to build, finance, own and operate a major component of Alberta's transmission infrastructure from the Wabamun area to the Fort McMurray area under the newly created Competitive Process. The AESO received submissions from ...

  • 15.01.2014 – 20:01

    Resverlogix Corp.

    Resverlogix Announces Combined RVX-208 Findings from SUSTAIN & ASSURE Phase 2b Trials

    Calgary, Alberta (ots/PRNewswire) - "RVX-208 treated patients have significant lower MACE events in high risk CVD patients" TSX Exchange Symbol: RVX Resverlogix Corp. today announced new information arising from its ongoing analysis of data from both the SUSTAIN and ASSURE trials in atherosclerotic patients with high risk for recurrent events. This analysis, performed ...

  • 06.12.2013 – 07:01

    Hitachi ID Systems, Inc.

    Hitachi ID Systems Opens UK Office

    Calgary, Alberta (ots/PRNewswire) - Demand for Hitachi ID products prompts expansion Hitachi ID Systems [http://hitachi-id.com ], a leading provider of identity and access management (IAM) solutions, is pleased to announce the opening of a new office in the United Kingdom. "Opening our new UK office was needed to accommodate the rapid increase in our European business," says Gideon Shoham, CEO. "This is a core component of our growth strategy and will allow us to expedite ...

  • 06.11.2013 – 05:20

    BNK Petroleum Inc.

    BNK Petroleum Inc. Announces 3rd Quarter 2013 results

    Calgary, Alberta (ots/PRNewswire) - All amounts are in U.S. Dollars unless otherwise indicated: Third Quarter Nine Months 2013 2012 % 2013 2012 % Earnings (Loss): $ Thousands $(2,445) $(4,260) - $(8,694) $(10,410) - $ per common share $ (0.02) $(0.03) - $(0.06) $(0.07) - assuming dilution Capital Expenditures $34,908 $12,691 175% $45,270 $35,592 27% Average Production (Boepd) 302 1,547 (80%) 743 1,547 (52%) Average ...

  • 29.08.2013 – 15:02

    Resverlogix Corp.

    Resverlogix Announces a Corporate Update Conference Call & Webcast

    Calgary, Alberta (ots/PRNewswire) - TSX Exchange Symbol: RVX Resverlogix Corp. today announced they will be hosting a corporate update conference call and webcast with Q&A on September 3rd at 11 am MDT. Details for the conference call and webcast are as follows: Link to webcast: http://services.choruscall.ca/links/resverlogix130905.html Dial in numbers: Canada & USA Toll Free Dial In: 1-800-319-4610 Outside of Canada & ...

  • 29.07.2013 – 18:31

    Alberta Electric System Operator

    Fort McMurray West Transmission Line Moves to Next Step

    Calgary, Alberta (ots/PRNewswire) - National and International Interest Shown in Project The Alberta Electric System Operator (AESO) is moving into the next stage of selecting a successful proponent for the Fort McMurray West 500 kV Transmission Project. The project will be the first in Alberta to use the Competitive Process, which is designed to maximize efficiency and provide downward pressure on transmission costs to ...

  • 15.05.2013 – 04:30

    BNK Petroleum Inc.

    BNK Petroleum Inc. Announces 1st Quarter 2013 Results

    Calgary, Alberta (ots/PRNewswire) - - TSX ticker symbol; BKX All amounts are in U.S. Dollars unless otherwise indicated: 2013 2012 % Earnings (Loss): $ Thousands $(5,320) $(3,520) L $ per common share assuming dilution $(0.04) $(0.02) L Capital Expenditures $2,492 $10,759 (77) Average production per day (Boepd) 1,674 1,654 1 Average Product Price per Barrel $34.69 $38.55 (10) Average Netback per Barrel $18.89 $18.08 4 ...

  • 18.04.2013 – 13:02

    Resverlogix Corp.

    Resverlogix Completes Dosing in ASSURE Clinical Trial

    Calgary, Alberta (ots/PRNewswire) - IVUS data will evaluate plaque regression in patients with high-risk Cardiovascular Disease TSX Exchange Symbol: RVX Resverlogix Corp. today announced that it has completed dosing in ASSURE, a Phase 2b clinical trial evaluating RVX-208, Resverlogix's first-in-class orally active BET-protein inhibitor, using intra-vascular ultrasound (IVUS) in high-risk cardiovascular patients with low ...

  • 12.04.2013 – 20:13

    RS Technologies Inc.

    RS Provides Update on CCAA Proceedings

    Calgary, Alberta (ots/PRNewswire) - RS Technologies Inc. ("RS" or the "Company"), an ISO 9001:2008 certified company that designs, engineers and manufactures composite utility poles, announced that it has taken several important steps under its Companies' Creditors Arrangement Act (Canada) ("CCAA") proceedings that were commenced on March 14, 2013. RS has obtained from the Alberta Court of Queen's Bench (the "Court") an ...

  • 27.03.2013 – 04:43

    BNK Petroleum Inc.

    BNK Announces 4th Quarter and Annual 2012 results

    Calgary, Alberta (ots/PRNewswire) - TSX ticker symbol; BKX All amounts are in U.S. Dollars unless otherwise indicated: Fourth Quarter Twelve Months 2012 2011 % 2012 2011 % Earnings (Loss): $ Thousands ($4,538) $687 L ($14,948) $705 L $ per common share ($0.03) $0.00 L ($0.10) $0.00 L assuming dilution Funds from operations: $ Thousands $(1,855) ($346) (436%) ($5,545) $5,972 L $ per common share ($0.01) ($0.00) - ($0.04) ...

  • 26.09.2012 – 13:32

    Resverlogix Corp.

    Resverlogix Completes Enrollment in ASSURE Trial

    Calgary, Alberta (ots/PRNewswire) - IVUS data will evaluate plaque regression in patients with Coronary Artery Disease TSX Exchange Symbol: RVX Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients. ASSURE will evaluate the ability of RVX-208, Resverlogix's BET protein inhibitor, to regress atherosclerotic disease versus ...

  • 05.09.2012 – 14:10

    Royal dutch shell plc

    Shell to Construct World's First Oil Sands Carbon Capture and Storage (CCS) Project

    Calgary, Alberta (ots/PRNewswire) - Shell today announced that it will go ahead with the first carbon capture and storage (CCS) project for an oil sands operation in Canada. The Quest project will be built on behalf of the Athabasca Oil Sands Project joint venture owners (Shell, Chevron and Marathon Oil[1]) and with support from the Governments of Canada and Alberta. ...

  • 28.08.2012 – 14:03

    Resverlogix Corp.

    Resverlogix's BET Protein Inhibitor RVX-208 Meets Primary Endpoint in SUSTAIN Clinical Trial in Patients With High Risk Cardiovascular Disease

    Munich And Calgary, Alberta (ots/PRNewswire) - -- Significant Increase in Functional HDL Persisted Throughout the 24-week Study Period -- -- Results from ASSURE Study Expected H1 2013, Using IVUS to Measure Regression of Atherosclerotic Plaque -- TSX Exchange Symbol: RVX Resverlogix Corp. today announced that the ...

  • 23.08.2012 – 11:02

    Calgary TELUS Convention Centre

    Calgary TELUS Convention Centre Goes Solar

    Calgary, Alberta (ots/PRNewswire) - ? Known for being a dynamic entrepreneurial city, Calgary is making exciting breakthroughs when it comes to innovative environmental initiatives. This year the Calgary Telus Convention Centre is introducing solar panels, which will generate power for meetings and conventions - and generate some attention for the city too. The Calgary TELUS Convention Centre (CTCC), one of Canada's ...

  • 09.08.2012 – 06:56

    BNK Petroleum Inc.

    BNK Petroleum Inc. Announces 2nd Quarter 2012 Results

    Calgary, Alberta (ots/PRNewswire) - All amounts are in U.S. Dollars unless otherwise indicated: Second Quarter First Half 2012 2011 % 2012 2011 % Earnings (Loss): $ Thousands $(2,630) $407 L $(6,150) $292 L $ per common share $(0.02) $0.00 L $(0.04) $0.00 L assuming dilution Capital Expenditures $12,583 $7,434 69% $23,355 $11,744 99% Average Production (Boepd) 1,439 1,308 10% 1,547 1,318 17% Average Product Price per ...

  • 23.04.2012 – 13:32

    Resverlogix Corp.

    Resverlogix' RVX-208 is the First BET Bromodomain Inhibitor in Clinical Trials

    Calgary, Alberta (ots/PRNewswire) - This Novel Epigenetic Mechanism Defines an Entirely New Class of Therapeutic TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") today announces the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production. Our data shows RVX-208 to be an inhibitor of the Bromodomain and ...

  • 19.04.2012 – 15:03

    Resverlogix Corp.

    Resverlogix Conference Call & Webcast to Announce Platform Mechanism of Action

    Calgary, Alberta (ots/PRNewswire) - Dr. Stephen J. Nicholls joins as guest speaker TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") is pleased to announce for the first time the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production. Please join us via Conference Call & Webcast on Monday, April 23, 2012, ...

  • 10.11.2011 – 12:55

    BNK Petroleum Inc.

    BNK Petroleum Inc. Announces 3rd Quarter 2011 results

    Calgary, Alberta, November 10 (ots/PRNewswire) - All amounts are in U.S. Dollars unless otherwise indicated: First Nine Third Quarter Months 2011 2010 % 2011 2010 % Earnings (Loss): $ Thousands ($274) ($1,464) 81% $18 ($3,895) P $ per common share $0.00 ($0.01) $0.00 ($0.04) P assuming dilution Funds from operations: $ Thousands $3,330 ($808) $6,281 ($17,129) $ per common share $0.02 ($0.01) $0.04 ($0.16) Capital ...